Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,345 INR | -1.53% | +5.01% | -0.82% |
May. 06 | Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India | MT |
Apr. 16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.82% | 1.23B | |
+21.35% | 43.92B | |
+22.93% | 23.09B | |
+19.25% | 15.35B | |
+13.63% | 13.61B | |
+47.32% | 12.02B | |
-10.29% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.6B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Unit's Injectable and Ophthalmic Plant in India Gets VAI Classification from US FDA